The present study revealed that the expression of FBXL16 decreases in the brains of APP/PSEN double transgenic mice, suggesting that a reduction in FBXL16 expression contributes to the dysregulation of protein homeostasis in neurons, potentially leading to the accumulation of abnormal proteins associated with AD. Here, APP is linked to Alzheimer disease.